Profile
Steven J.
Swanson worked as the Head of Clinical Immunology at Amgen, Inc. He then worked as the Senior Vice President of Research at ImmunoCellular Therapeutics Ltd.
from 2015 to 2018.
Swanson received his undergraduate degree from North Central College and his doctorate from the University of Iowa.
Former positions of Steven J. Swanson
| Companies | Position | End |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2018-10-14 |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Steven J. Swanson
| North Central College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
- Stock Market
- Insiders
- Steven J. Swanson
